María Asunción Esteve-Pastor

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 18

Top Venues

Thrombosis and haemostasis

European journal of clinical investigation

International journal of clinical practice

Journal of cardiovascular pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

María Asunción Esteve-Pastor, Eva Soler, Francisco Marín
Reticulated platelets: a promising prognosis marker in cardiovascular diseases. Thrombosis and haemostasis (2023)
María Asunción Esteve-Pastor, José Miguel Rivera-Caravaca, Vanessa Roldán, Marcelo Sanmartín Fernández, Fernando Arribas, Jaime Masjuan, Vivencio Barrios, Juan Cosin-Sales, Román Freixa-Pamias, Esther Recalde, Alejandro I Pérez-Cabeza, José Manuel Vázquez Rodríguez, Carles Ráfols Priu, Manuel Anguita Sánchez, Gregory Y H Lip, Francisco Marín
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry. European heart journal. Cardiovascular pharmacotherapy (2022)
María Asunción Esteve-Pastor, Jose Miguel Rivera-Caravaca, Martín Ruiz-Ortiz, Javier Muñiz, Inmaculada Roldán-Rabadán, Déborah Otero, Raquel López-Gálvez, Ángel Cequier, Vicente Bertomeu-Martínez, Lina Badimón, Manuel Anguita, Gregory Y H Lip, Francisco Marín, null null
A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry. Expert opinion on pharmacotherapy 23 (12) (2022)
María Asunción Esteve-Pastor, Ernesto Martín, Oriol Alegre, Francesc Formiga, Juan Sanchís, Ramón López-Palop, Manuel Martínez Sellés, María Teresa Vidán, Héctor Bueno, Pablo Díez-Villanueva, Emad Abu Assi, Albert Ariza-Solé, Francisco Marín, Juan Carlos Castillo Dominguez, null null
Impact of frailty and atrial fibrillation in elderly patients with acute coronary syndromes. European journal of clinical investigation 51 (5) (2021)
Marco Proietti, Jose Miguel Rivera-Caravaca, María Asunción Esteve-Pastor, Francísco Marín, Gregory Yoke Hong Lip
Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores. Thrombosis and haemostasis 121 (8) (2020)
Martín Ruiz Ortiz, Javier Muñiz, María Asunción Esteve-Pastor, Francisco Marín, Inmaculada Roldán, Angel Cequier, Manuel Martínez-Sellés, Hugo González Saldivar, Vicente Bertomeu, Manuel Anguita
Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA Study. Journal of cardiovascular pharmacology and therapeutics 25 (4) (2020)
Vivencio Barrios, José Moreno-Arribas, María Asunción Esteve-Pastor, Inmaculada Roldán-Rabadán, Javier Muñiz, Déborah Otero García, Martín Ruiz Ortiz, Ángel Cequier, Vicente Bertomeu-Martínez, Lina Badimón, Manuel Anguita, Gregory Y H Lip, Francisco Marín, null null
Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry. European journal of clinical investigation 51 (4) (2020)
Jose Miguel Rivera-Caravaca, Pablo Gil-Perez, Cecilia Lopez-García, Andrea Veliz-Martínez, Miriam Quintana-Giner, Ana Isabel Romero-Aniorte, Concepción Fernandez-Redondo, Luis Muñoz, Eva Quero, María Asunción Esteve-Pastor, Gregory Yoke Hong Lip, Vanessa Roldán Schilling, Francisco Marín
A nurse-led atrial fibrillation clinic: Impact on anticoagulation therapy and clinical outcomes. International journal of clinical practice 74 (12) (2020)
Juan Miguel Ruiz-Nodar, María Asunción Esteve-Pastor, Jose Miguel Rivera-Caravaca, Miriam Sandín, Teresa Lozano, Nuria Vicente-Ibarra, Esteban Orenes-Piñero, Manuel Jesús Macías, Vicente Pernías, Luna Carrillo, Elena Candela, Andrea Veliz, Antonio Tello-Montoliu, Juan Gabriel Martínez Martínez, Francisco Marín
One-year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry. British journal of clinical pharmacology 86 (6) (2020)
Jose Miguel Rivera-Caravaca, María Asunción Esteve-Pastor, Anny Camelo-Castillo, Inmaculada Ramírez-Macías, Gregory Yoke Hong Lip, Vanessa Roldán Schilling, Francisco Marín
Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy. Expert opinion on pharmacotherapy 21 (15) (2020)
Jose Miguel Rivera-Caravaca, María Asunción Esteve-Pastor
Heart Failure and Cardiac Events: Is a Consecutive Measurement of Biomarkers a Simple and Practical Approach? Thrombosis and haemostasis 119 (12) (2019)
María Asunción Esteve-Pastor, Vanessa Roldán, Jose Miguel Rivera-Caravaca, Inmaculada Ramírez-Macías, Gregory Yoke Hong Lip, Francisco Marín
The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal. Thrombosis and haemostasis 119 (12) (2019)
Jose Miguel Rivera-Caravaca, Francisco Marín, María Asunción Esteve-Pastor, Josefa Gálvez, Gregory Yoke Hong Lip, Vicente Vicente, Vanessa Roldán Schilling
Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation. BMJ open 9 (12) (2019)
Jose Miguel Rivera-Caravaca, Francisco Marín, María Asunción Esteve-Pastor, Mariano Valdés, Vicente Vicente, Vanessa Roldán, Gregory Y H Lip
Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality. International journal of clinical practice 72 (3) (2018)
María José Serna, Jose Miguel Rivera-Caravaca, Rocío Gonzalez-Conejero, María Asunción Esteve-Pastor, Mariano Valdés, Vicente Vicente, Gregory Y H Lip, Vanessa Roldán, Francisco Marín
Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation. European journal of clinical investigation 48 (6) (2018)
Antonio Tello-Montoliu, Juan Miguel Ruiz-Nodar, María Asunción Esteve-Pastor, Andrea Véliz-Martínez, Esteban Orenes-Piñero, Manuel J Macías-Villanego, Teresa Lozano, Luna Carrillo-Alemán, Nuria Vicente-Ibarra, Vicente Pernias-Escrig, Juan G Martínez-Martínez, Jose Miguel Rivera-Caravaca, Francisco Marín
Chronic Kidney Disease and Third-Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year. Journal of clinical pharmacology 59 (2) (2018)
María Asunción Esteve-Pastor, Juan Miguel Ruíz-Nodar, Esteban Orenes-Piñero, José Miguel Rivera-Caravaca, Miriam Quintana-Giner, Andrea Véliz-Martínez, Antonio Tello-Montoliu, Vicente PerniasEscrig, Miriam Sandín Rollán, Nuria Vicente-Ibarra, Manuel Jesús MacíasVillanego, Elena Candela Sánchez, Luna Carrillo Alemán, Teresa Lozano, Mariano Valdés, Francisco Marín
Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes. Journal of cardiovascular pharmacology and therapeutics 23 (1) (2017)
Jose Miguel Rivera-Caravaca, Vanessa Roldán, María Asunción Esteve-Pastor, Mariano Valdés, Vicente Vicente, Gregory Y H Lip, Francisco Marín
Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation. Scientific reports 7 (1) (2017)

María Asunción Esteve-Pastor.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

María Asunción Esteve-Pastor